FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.4  |  FHIR Version n/a  User: [n/a]

50841000172109: Belgian subset for AllergyIntolerance, causative agent, drug (foundation metadata concept)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 15-Nov 2022. Module: Belgian module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module
7891641000172111 Belgian subset for AllergyIntolerance, causative agent, drug en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) Belgian module (core metadata concept)
7891651000172113 Belgian subset for AllergyIntolerance, causative agent, drug (foundation metadata concept) en Fully specified name Active Only initial character case insensitive (core metadata concept) Belgian module (core metadata concept)
7891661000172110 sous-ensemble belge pour AllergyIntolerance, agent causal, médicaments fr Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) Belgian module (core metadata concept)
7891671000172118 Belgische subset voor AllergyIntolerance, oorzakelijk agens, medicatie nl Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) Belgian module (core metadata concept)


6399 members. Search Members:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Belgian subset for AllergyIntolerance, causative agent, drug Is a Simple type reference set (foundation metadata concept) true Inferred relationship Some

Members
Streptomycin (substance)
Streptomycin sulfate
Streptozocin (substance)
Strong silver protein
Strontium
Strontium ranelate (substance)
Strophanthin
Styramate
Storax
Styrylpyridinium chloride
Substance P
HMG-CoA reductase inhibitor
Substance with 4-hydroxyphenylpyruvate dioxygenase inhibitor mechanism of action (substance)
5-HT3 receptor antagonist
C1 esterase inhibitor
C1q esterase inhibitor
Cytomegalovirus terminase complex inhibitor
Hepatitis C virus NS3/4A protease inhibitor
Hepatitis C virus protein NS5A inhibitor
Hepatitis C virus protein NS5B inhibitor
Substance with Human immunodeficiency virus fusion inhibitor mechanism of action (substance)
NAD(P)H dehydrogenase (quinone) inhibitor
P2Y12 G-protein-coupled platelet receptor antagonist
RNA polymerase inhibitor
Acaricide
Acetylcholine receptor agonist
Acetylcholine receptor antagonist
Acetylcholinesterase inhibitor
Acetylcholinesterase reactivator
Activated protein C inhibitor
Adenosine A2 receptor agonist
Substance with adrenergic neurone blocker mechanism of action (substance)
Adrenergic receptor agonist
Alcohol dehydrogenase inhibitor
Substance with aldehyde dehydrogenase inhibitor mechanism of action (substance)
Aldosterone receptor antagonist
Alkaline phosphatase inhibitor
Alpha adrenergic receptor agonist
Alpha adrenergic receptor antagonist
Alpha-1 adrenergic receptor antagonist
Alpha-2 adrenergic receptor agonist
Alpha-2 adrenergic receptor antagonist
Alpha-4 integrin receptor antagonist
Substance with alpha-adrenergic and beta-adrenergic agonist mechanism of action (substance)
Substance with alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor antagonist mechanism of action (substance)
Substance with aminoglycoside structure and antibacterial mechanism of action (substance)
Androgen receptor agonist
Angiotensin II receptor antagonist
Angiotensin-converting enzyme inhibitor
Anion exchange resin
Anthelmintic
Antibacterial
Antifungal
Substance with antimalarial mechanism of action (substance)
Substance with antimycobacterial mechanism of action (substance)
Antiprotozoal
Substance with antiretroviral mechanism of action (substance)
Substance with antiviral mechanism of action (substance)
Aromatase inhibitor
Azole antifungal
Benzodiazepine receptor antagonist
Beta adrenergic receptor agonist
Substance with beta adrenergic receptor antagonist mechanism of action (substance)
Selective beta-1 adrenoceptor agonist
Beta-1 adrenergic receptor antagonist
Substance with beta-2 adrenergic receptor agonist mechanism of action (substance)
Substance with beta-2 adrenergic receptor antagonist mechanism of action (substance)
Selective beta-3 agonist
Substance with beta-lactam structure and antibacterial mechanism of action (substance)
Bradykinin B2 inhibitor
Calcineurin inhibitor
Calcium channel blocker
Substance with calcium-sensing receptor activator mechanism of action (substance)
Cannabinoid receptor agonist
Catechol-O-methyltransferase inhibitor
Substance with central alpha-2 adrenergic receptor agonist mechanism of action (substance)
Centrally acting acetylcholinesterase inhibitor
Coagulation factor Xa inhibitor
Coagulation factor inhibitor
Substance with cyclic lipopeptide structure and antibacterial mechanism of action (substance)
Dihydrofolate reductase inhibitor
Dihydropyridine derivative calcium channel blocker
Substance with dihydroxyphenylalanine decarboxylase inhibitor mechanism of action (substance)
Direct thrombin inhibitor
Substance with dopamine receptor D2 antagonist mechanism of action
Dopamine receptor antagonist
Endothelin receptor antagonist
Enzyme inhibitor
Epidermal growth factor receptor inhibitor
Erythropoietin receptor agonist
Substance with estrogen receptor agonist mechanism of action (substance)
Fibroblast growth factor receptor inhibitor
GABA receptor antagonist
Ganglion blocking agent
Glutamate receptor antagonist
Glycopeptide antibiotic
Substance with glycoprotein-IIb/IIIa receptor antagonist mechanism of action (substance)
Gonadotropin
Gonadotropin releasing hormone receptor antagonist
Guanylate cyclase 2C agonist
Histamine H1 receptor antagonist

Start Previous Page 54 of 64 Next End


Reference Sets

Reference set descriptor

Back to Start